HAYWARD, Calif., Dec. 17, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it has made a $25,000 donation to the Children's Hospital & Research Center Oakland in support of the Early Intervention Services program.
Children's Hospital & Research Center Oakland is a premier, not-for-profit medical center for children in Northern California, and is the only hospital in the East Bay that is 100% devoted to pediatrics. Their Early Intervention Services program supports the well-being, development and caregiving relationships of infants and young children (up to age 6) who have developmental, social-emotional and medically related vulnerabilities or disabilities.
"Questcor is committed to giving back to our local community," said Steve Cartt, Chief Operating Officer for Questcor. "We feel privileged to be able to support such a worthy institution, particularly one that is funded solely by grants and charitable contributions. Our hope is that these funds will help improve the quality of life for some Bay Area children who are in need."
In addition to the financial contribution, Mr. Cartt noted that Questcor employees in Hayward created get well cards for children being treated at the hospital. These cards are distributed to children on their lunch trays. "In addition to the donation, we wanted to find a way to more personally connect with the children and their families, especially during the holiday season," Mr. Cartt said. "This seemed to be a great way to do it."
Susan Greenwald, Director of Early Intervention Services, shared, "We're grateful for Questcor's generous donation and look forward to putting the money to good use serving children and families. We also appreciate the time and effort Questcor employees gave to produce beautiful get-well cards. I know they will help lift the spirits of our courageous young patients."
About Children's Hospital & Research Center
Children's Hospital & Research Center Oakland is a national leader in many pediatric specialties including hematology/oncology, neonatology, cardiology, orthopaedics, sports medicine, and neurosurgery. The hospital is one of only two solely designated California Level 1 pediatric trauma centers in the region, and has one of largest pediatric intensive care units in Northern California. Children's is also a leading teaching hospital with an outstanding pediatric residency program and a number of unique pediatric subspecialty fellowship programs.
Children's research arm, Children's Hospital Oakland Research Institute is internationally known for its basic and clinical research. CHORI is at the forefront of translating research into interventions for treating and preventing human diseases.
Each year, more than 75,000 children from the San Francisco Bay Area and the country receive care. No child is turned away because of a family's inability to pay. For more information, please visit www.childrenshospitaloakland.org.
About Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's specific areas of focus are in the fields of neurology, nephrology and rheumatology, and the company is currently supporting research efforts in a variety of conditions having significant unmet medical need. For more information about Questcor, please visit www.questcor.com.
SOURCE Questcor Pharmaceuticals, Inc.
News Provided by Acquire Media